<DOC>
	<DOC>NCT02443246</DOC>
	<brief_summary>To compare the efficacy of Vitamin D3 B.O.N. Intramuscular Injection within 12 weeks with that of placebo in adults with Vitamin D Deficiency.</brief_summary>
	<brief_title>A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Subjects with vitamin D deficiency Subjects who experienced a hypersensitivity to the cholecalciferol Subjects with renal impairment Subjects with Hypercalcemia Subjects with Hypercalciuria Subjects with clinically doubted calcium stone Subjects diagnosed with sarcoidosis Subjected diagnosed with pseudohypoparathyroidism Subjected with malignancy Subjects with clinically significant cardiovascular or lung impairment Judged by the investigator Subjects with the below laboratory abnormality (Platelet, WBC, Absolute neutrophil count, Albumin, AST or ALT) Subjects who are to take vitamin D supplements during the study period</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>